Want to see TYRA full AI Analyst Report?

Tyra Bioscience (TYRA) Stock Forecast & Price Target

144 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TYRA Analyst Ratings

Strong Buy

11 Buy

1 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Tyra

Bioscience

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TYRA Stock 12 Month Forecast

Average Price Target

$49.63

▲(62.01% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Tyra Bioscience in the last 3 months. The average price target is $49.63 with a high forecast of $59.00 and a low forecast of $42.00. The average price target represents a 62.01% change from the last price of $30.63.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"$9","60":"$60","21.75":"$21.8","34.5":"$34.5","47.25":"$47.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":59,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$59.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":49.625,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$49.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":42,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$42.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,21.75,34.5,47.25,60],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.88,33.966153846153844,36.05230769230769,38.138461538461534,40.22461538461538,42.310769230769225,44.39692307692307,46.48307692307692,48.56923076923077,50.65538461538461,52.741538461538454,54.8276923076923,56.91384615384615,{"y":59,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.88,33.245,34.61,35.975,37.339999999999996,38.705,40.07,41.435,42.8,44.165,45.53,46.894999999999996,48.26,{"y":49.625,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.88,32.65846153846154,33.43692307692308,34.215384615384615,34.99384615384615,35.77230769230769,36.550769230769234,37.32923076923077,38.107692307692304,38.886153846153846,39.66461538461539,40.44307692307692,41.22153846153846,{"y":42,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.37,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.53,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.42,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.84,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.81,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.29,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.02,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.52,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.28,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.04,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.39,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.41,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.88,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$59.00

Average Price Target$49.63

Lowest Price Target$42.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Sami Corwin

William Blair

―

Buy

―

Reiterated

08/05/26

Analysts Are Bullish on Top Healthcare Stocks: Alphatec Holdings (ATEC), Tyra Bioscience (TYRA)

Mitchell Kapoor

H.C. Wainwright

$45

Buy

46.91%

Upside

Reiterated

08/05/26

Analyst Reiterates Buy on Tyra, Maintaining $45 Price Target Ahead of Key SURF302 Phase 2 Readout

Maury Raycroft

Jefferies

$44→$42

Buy

37.12%

Upside

Reiterated

08/05/26

Tyra Biosciences price target lowered to $42 from $44 at JefferiesTyra Biosciences price target lowered to $42 from $44 at Jefferies

Robert Driscoll

Wedbush

$53

Buy

73.03%

Upside

Reiterated

08/05/26

Tyra Bioscience (TYRA) Gets a Buy from Wedbush

Boris Peaker

JonesTrading

$56

Buy

82.83%

Upside

Reiterated

08/04/26

Tyra Biosciences: Boris Peaker Reaffirms Buy Rating with $56 Price Target on Strength of FGFR3 Pipeline and Upcoming SURF-302/BEACH-301 Data

John Newman

Canaccord Genuity

$50

Buy

63.24%

Upside

Reiterated

08/03/26

Canaccord Genuity Reaffirms Their Buy Rating on Tyra Bioscience (TYRA)

Mazahir Alimohamed

Oppenheimer

$50

Buy

63.24%

Upside

Reiterated

07/31/26

Tyra Bioscience (TYRA) Gets a Buy from Oppenheimer

Christopher Raymond

Raymond James

―

Buy

―

Reiterated

07/17/26

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Eli Lilly & Co (LLY)

Jason Zemansky

Bank of America Securities

$37→$42

Buy

37.12%

Upside

Reiterated

06/10/26

Tyra Biosciences price target raised to $42 from $37 at BofATyra Biosciences price target raised to $42 from $37 at BofA

Eliana Merle

Barclays

$59

Buy

92.62%

Upside

Reiterated

06/03/26

Barclays Keeps Their Buy Rating on Tyra Bioscience (TYRA)

Kalpit Patel

Wolfe Research

―

Hold

―

Initiated

05/19/26

Tyra Biosciences initiated with a Peer Perform at Wolfe ResearchTyra Biosciences initiated with a Peer Perform at Wolfe Research

Tyler Van Buren

TD Cowen

―

Buy

―

Reiterated

05/13/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: West Pharmaceutical Services (NYSE: WST), CalciMedica (NASDAQ: CALC) and Tyra Bioscience (NASDAQ: TYRA)

Bradley Canino

Guggenheim

$54

Buy

76.30%

Upside

Initiated

04/15/26

Tyra Biosciences initiated with a Buy at GuggenheimTyra Biosciences initiated with a Buy at Guggenheim

Allison Bratzel

Piper Sandler

$42→$56

Buy

82.83%

Upside

Reiterated

03/20/26

Tyra Bioscience (TYRA) Receives a Buy from Piper Sandler

Li Watsek

Cantor Fitzgerald

―

Buy

―

Reiterated

03/04/26

Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and Tyra Bioscience (NASDAQ: TYRA)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Sami Corwin

William Blair

―

Buy

―

Reiterated

08/05/26

Analysts Are Bullish on Top Healthcare Stocks: Alphatec Holdings (ATEC), Tyra Bioscience (TYRA)

Mitchell Kapoor

H.C. Wainwright

$45

Buy

46.91%

Upside

Reiterated

08/05/26

Analyst Reiterates Buy on Tyra, Maintaining $45 Price Target Ahead of Key SURF302 Phase 2 Readout

Maury Raycroft

Jefferies

$44→$42

Buy

37.12%

Upside

Reiterated

08/05/26

Tyra Biosciences price target lowered to $42 from $44 at JefferiesTyra Biosciences price target lowered to $42 from $44 at Jefferies

Robert Driscoll

Wedbush

$53

Buy

73.03%

Upside

Reiterated

08/05/26

Tyra Bioscience (TYRA) Gets a Buy from Wedbush

Boris Peaker

JonesTrading

$56

Buy

82.83%

Upside

Reiterated

08/04/26

Tyra Biosciences: Boris Peaker Reaffirms Buy Rating with $56 Price Target on Strength of FGFR3 Pipeline and Upcoming SURF-302/BEACH-301 Data

John Newman

Canaccord Genuity

$50

Buy

63.24%

Upside

Reiterated

08/03/26

Canaccord Genuity Reaffirms Their Buy Rating on Tyra Bioscience (TYRA)

Mazahir Alimohamed

Oppenheimer

$50

Buy

63.24%

Upside

Reiterated

07/31/26

Tyra Bioscience (TYRA) Gets a Buy from Oppenheimer

Christopher Raymond

Raymond James

―

Buy

―

Reiterated

07/17/26

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Eli Lilly & Co (LLY)

Jason Zemansky

Bank of America Securities

$37→$42

Buy

37.12%

Upside

Reiterated

06/10/26

Tyra Biosciences price target raised to $42 from $37 at BofATyra Biosciences price target raised to $42 from $37 at BofA

Eliana Merle

Barclays

$59

Buy

92.62%

Upside

Reiterated

06/03/26

Barclays Keeps Their Buy Rating on Tyra Bioscience (TYRA)

Kalpit Patel

Wolfe Research

―

Hold

―

Initiated

05/19/26

Tyra Biosciences initiated with a Peer Perform at Wolfe ResearchTyra Biosciences initiated with a Peer Perform at Wolfe Research

Tyler Van Buren

TD Cowen

―

Buy

―

Reiterated

05/13/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: West Pharmaceutical Services (NYSE: WST), CalciMedica (NASDAQ: CALC) and Tyra Bioscience (NASDAQ: TYRA)

Bradley Canino

Guggenheim

$54

Buy

76.30%

Upside

Initiated

04/15/26

Tyra Biosciences initiated with a Buy at GuggenheimTyra Biosciences initiated with a Buy at Guggenheim

Allison Bratzel

Piper Sandler

$42→$56

Buy

82.83%

Upside

Reiterated

03/20/26

Tyra Bioscience (TYRA) Receives a Buy from Piper Sandler

Li Watsek

Cantor Fitzgerald

―

Buy

―

Reiterated

03/04/26

Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and Tyra Bioscience (NASDAQ: TYRA)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

TNYATenaya Therapeutics

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tyra Bioscience

3 Months

Mitchell KapoorH.C. Wainwright

Success Rate

18/29 ratings generated profit

Average Return

+12.22%

Copying Mitchell Kapoor's trades and holding each position for 3 Months would result in 62.07% of your transactions generating a profit, with an average return of +12.22% per trade.

1 Year

Jason ZemanskyBank of America Securities

Success Rate

8/12 ratings generated profit

Average Return

+70.92%

Copying Jason Zemansky's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +70.92% per trade.

2 Years

Mitchell KapoorH.C. Wainwright

Success Rate

23/29 ratings generated profit

Average Return

+75.40%

Copying Mitchell Kapoor's trades and holding each position for 2 Years would result in 79.31% of your transactions generating a profit, with an average return of +75.40% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TYRA Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TYRA has received 21 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TYRA average Analyst price target in the past 3 months is 49.63.

Each month's total comprises the sum of three months' worth of ratings.

TYRA Financial Forecast

TYRA Earnings Forecast

Next quarter’s earnings estimate for TYRA is -$0.68 with a range of -$0.76 to -$0.59. The previous quarter’s EPS was -$0.69. TYRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.32% of the time in the same period. In the last calendar year TYRA has Performed in-line its overall industry.

No data currently available

TYRA Sales Forecast

Next quarter’s sales forecast for TYRA is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. TYRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 31.16% of the time in the same period. In the last calendar year TYRA has Performed in-line its overall industry.

TYRA Stock Forecast FAQ

What is TYRA’s average 12-month price target, according to analysts?

Based on analyst ratings, Tyra Bioscience’s 12-month average price target is 49.63.

What is TYRA’s upside potential, based on the analysts’ average price target?

Tyra Bioscience has 62.01% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TYRA a Buy, Sell or Hold?

Tyra Bioscience has a consensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.

What is Tyra Bioscience’s price target?

The average price target for Tyra Bioscience is 49.63. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $59.00 ,the lowest forecast is $42.00. The average price target represents 62.01% Increase from the current price of $30.63.

What do analysts say about Tyra Bioscience?

Tyra Bioscience’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of TYRA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Tyra Bioscience (TYRA) Stock Forecast & Price Target

TYRA Analyst Ratings

TYRA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Tyra Bioscience

TYRA Analyst Recommendation Trends

TYRA Financial Forecast

TYRA Earnings Forecast

TYRA Sales Forecast

TYRA Stock Forecast FAQ

Detailed List of Analyst Forecasts